<DOC>
	<DOC>NCT03103490</DOC>
	<brief_summary>The investigators will evaluate the detection of cardiac sarcoidosis or inflammation using 18F-FSPG PET/MRI.</brief_summary>
	<brief_title>PET/MR Imaging of Cardiac Sarcoidosis or Inflammation</brief_title>
	<detailed_description>PET/MRI scans will be performed with a whole-body PET/MR imaging system capable of simultaneous PET and MR imaging (SIGNA, GE Healthcare, Milwaukee, WI). Approximately 45-60 minutes after IV injection of 8 mCi of 18F-FSPG, PET emission scanning and MRI acquisition T1 weighted scanning will begin imaging both whole body and the heart.</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Myocarditis</mesh_term>
	<criteria>Patient is â‰¥ 18 years old at the time of the scan Patient with known or suspected cardiac sarcoidosis. Patient is capable of complying with study procedures Patient can remain still for duration of imaging procedure Patient is pregnant or nursing Metallic implants (contraindicated for MRI) History of renal insufficiency (only for MRI contrast administration)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>PET/MR</keyword>
</DOC>